Title : Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade.

Pub. Date : 2015 Dec

PMID : 26257239






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib enriches epithelial cell adhesion molecule-positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 The TSC2-AKT cascade mediates this sorafenib resistance. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 In response to sorafenib treatment, formation of the TSC1/2 complex is enhanced, causing increased phosphorylation of AKT, which contributes to up-regulation of "stemness"-related genes in epithelial cell adhesion molecule-positive cells and enhancement of tumorigenicity. Sorafenib AKT serine/threonine kinase 1 Homo sapiens